Xoma Royalty Corp
SEC CIK 791908 · XOMAD · last insider filing 2026-05-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wyszomierski Jack L | Director | filed 2010–2026 |
| Limber Joseph M | Director | filed 2012–2026 |
| Franklin Heather L | Director | filed 2021–2026 |
| Perry Matthew D | Director | filed 2017–2026 |
| Kosacz Barbara | Director | filed 2019–2026 |
| Hernday Natasha | Director | filed 2020–2026 |
| BVF Partners L P/IL | Director | filed 2017–2026 |
| BVF INC/IL | Director | filed 2017–2026 |
| Biotechnology Value Fund II LP | Director | filed 2017–2026 |
| Lampert Mark N | Director | filed 2017–2026 |
| Biotechnology Value Trading Fund OS LP | Director | filed 2017–2026 |
| BVF Partners OS Ltd. | Director | filed 2017–2026 |
| BVF I GP LLC | Director | filed 2020–2026 |
| BVF II GP LLC | Director | filed 2020–2026 |
| BVF GP Holdings LLC | Director | filed 2020–2026 |
| Biotechnology Value Fund L P | Director | filed 2017–2026 |
| Hughes Owen | Director · Interim CEO | filed 2023–2026 |
| Neal James R | Director · VP Business Development | filed 2014–2022 |
| VAN Ness W Denman | Director | filed 2006–2022 |
| Hutt Peter Barton | Director | filed 2006–2017 |
| Walbert Timothy P | Director | filed 2010–2017 |
| Varian John | Director · Director and CEO | filed 2008–2017 |
| Scannon Patrick J MD PHD | Director · Executive Vice President | filed 2006–2016 |
| Baker Julian | Director | filed 2012–2015 |
| Baker Felix | Director | filed 2012–2015 |
| Baker Bros. Advisors LP | Director | filed 2012–2015 |
| Baker Brothers Life Sciences LP | Director | filed 2012–2015 |
| 14159, L.P. | Director | filed 2012–2015 |
| 667, L.P. | Director | filed 2012–2015 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2013–2015 |
| Bowes William K JR | Director | filed 2006–2015 |
| Neu Kelvin | Director | filed 2012–2012 |
| Engle Steven B | Director · Chairman, CEO & President | filed 2007–2011 |
| Fisher Charles J JR | Director | filed 2007–2011 |
| Zenner Patrick J | Director | filed 2006–2010 |
| Andress James G | Director | filed 2006–2008 |
| Castello John L | Director · President, CEO and | filed 2006–2008 |
| Kornberg Arthur MD | Director | filed 2006–2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Trigilio Jeffrey | Chief Financial Officer | filed 2026–2026 |
| Sitko Bradley | Chief Investment Officer | filed 2023–2026 |
| Montano Maricel Perea | Chief Legal Officer | filed 2025–2026 |
| Burns Thomas M. | VP, Finance & Chief Financial | filed 2015–2025 |
| Datta Deepshikha | Chief Business Officer | filed 2018–2019 |
| Rubin Paul D | VP Clinical Dev. & CMO | filed 2011–2016 |
| Kurland Fred | VP Finance | filed 2009–2015 |
| Klein Thomas | Chief Commercial Officer | filed 2013–2015 |
| Margolin Christopher J | VP, General Counsel & Sec'y | filed 2006–2012 |
| Boyle J David II | VP, Finance, and CFO | filed 2006–2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.